Br J Ophthalmol 2000;84:914-916
( August )
Scientific correspondence
Local intra-arterial fibrinolysis for acute occlusion of the
central retinal artery: a meta-analysis of the published data
S Beatty, K G Au Eong
Academic
Department of Ophthalmology, Manchester Royal Eye Hospital
Correspondence to: S Beatty, Medical Retina Unit, Department of Clinical Ophthalmology,
Moorfields Eye Hospital, City Road, London EC1V 2PD
stephen{at}stiofanbetagh.demon.co.uk
Accepted for publication 16 March 2000
BACKGROUND/AIM Central
retinal artery occlusion (CRAO) is typically associated with a poor
visual outcome. Several favourable reports of local intra-arterial
fibrinolysis (LIF), which involves the superselective administration of
a thrombolytic agent directly into the ophthalmic artery, have appeared
in the recent literature. The aim of this study was to critically
appraise these studies in a collective fashion.
METHODS A
meta-analysis was performed of all the published literature germane to
LIF in cases of CRAO.
RESULTS Of the 16 studies identified, all were retrospective and non-randomised. After
correction for data duplication, the results of LIF in 100 patients can
be reported. A final acuity of 6/6 or better was seen in 14% of
patients following LIF, and a visual result of 6/12 or better was seen
in 27% of subjects. A poor final acuity of 3/60 or worse was seen in
60.6% of eyes treated with local intra-arterial fibrinolysis. These
results compare favourably with conventional forms of therapy.
Potentially serious complications were seen in four patients, but no
patient suffered a permanent neurological deficit.
CONCLUSION The results
of this study suggest that there may be a marginal visual benefit
associated with LIF compared with conventional management of CRAO.
However, the methodology of the cited studies was often unsatisfactory,
and a randomised controlled trial of LIF in cases of CRAO is justified.
Outside of a randomised clinical trial, the use of superselective
fibrinolytic therapy for CRAO cannot be recommended on the basis of
current evidence.
© 2000 by British Journal of Ophthalmology
This article has been cited by other articles:

|
 |

|
 |
 
E. M. Aldrich, A. W. Lee, C. S. Chen, R. F. Gottesman, M. N. Bahouth, P. Gailloud, K. Murphy, R. Wityk, and N. R. Miller
Local Intraarterial Fibrinolysis Administered in Aliquots for the Treatment of Central Retinal Artery Occlusion: The Johns Hopkins Hospital Experience
Stroke,
June 1, 2008;
39(6):
1746 - 1750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Hayreh
Intra-arterial thrombolysis for central retinal artery occlusion
Br. J. Ophthalmol.,
May 1, 2008;
92(5):
585 - 587.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Noble, N Weizblit, M O Baerlocher, and K T Eng
Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review
Br. J. Ophthalmol.,
May 1, 2008;
92(5):
588 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Garcia-Arumi, V Martinez-Castillo, A Boixadera, A Fonollosa, and B Corcostegui
Surgical embolus removal in retinal artery occlusion
Br. J. Ophthalmol.,
October 1, 2006;
90(10):
1252 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Arnold, U Koerner, L Remonda, K Nedeltchev, H P Mattle, G Schroth, M Sturzenegger, J Weber, and F Koerner
Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion
J. Neurol. Neurosurg. Psychiatry,
February 1, 2005;
76(2):
196 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|